Glaukos, located in Laguna Hills, CA, is dedicated to pioneering new treatments for chronic eye diseases. The company focuses on developing innovative therapies that elevate the standard of care and provide enhanced treatment options for patients globally.
Specializing in cornea cross-linking interventions to slow or halt progressive keratoconus, Glaukos aims to preserve patients' vision effectively. Additionally, the company offers a market-leading portfolio of cutting-edge glaucoma therapies and is actively developing sustained-release drug delivery platforms for retinal diseases.
Committed to continuous innovation, Glaukos reinvests a significant portion of its sales into research and development activities. With a strong emphasis on transforming standards of care and improving patient lives, the company's unwavering dedication to advancing transformative therapies showcases its pivotal role in the ophthalmic market.
Generated from the website content
